Back
iShares BB Rated Corporate Bond ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Sell
38
HYBB
iShares BB Rated Corporate Bond ETF
Last Price:
$47.28
Seasonality Move:
-1.9%
Buy
67
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$86.89
Seasonality Move:
-40.64%
Sell
38
iShares BB Rated Corporate Bond ETF (HYBB)
is a Sell
Is iShares BB Rated Corporate Bond ETF a Buy, Sell or Hold?
-
The current iShares BB Rated Corporate Bond ETF [HYBB] share price is $47.21. The Score for HYBB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
HYBB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $90.01. The Score for DRUG is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HYBB Stock Price Chart
What is iShares BB Rated Corporate Bond ETF's stock price today?
-
The iShares BB Rated Corporate Bond ETF share price today is $47.21Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HYBB is experiencing slight buying pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $90.01The current trend is moderately bullish and DRUG is experiencing slight selling pressure.
HYBB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 54.21 | Buy |
| Chaikin Money Flow: | -7261 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.04 - 47.2) | Buy |
| Bollinger Bands (100): | (46.95 - 47.27) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.79 | Buy |
| Relative Strength Index (14 RSI): | 58.71 | Buy |
| Chaikin Money Flow: | -196363 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (75.34 - 89.1) | Buy |
| Bollinger Bands (100): | (46.01 - 75.51) | Buy |
HYBB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.18 | Buy |
| 20-day SMA: | 47.11 | Buy |
| 50-day SMA: | 47.11 | Buy |
| 200-day SMA: | 46.68 | Buy |
| 8-day EMA: | 47.19 | Buy |
| 20-day EMA: | 47.14 | Buy |
| 50-day EMA: | 47.11 | Buy |
| 200-day EMA: | 46.84 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.17 | Buy |
| 20-day SMA: | 84.39 | Buy |
| 50-day SMA: | 70.26 | Buy |
| 200-day SMA: | 45.73 | Buy |
| 8-day EMA: | 86.85 | Buy |
| 20-day EMA: | 82.54 | Buy |
| 50-day EMA: | 73.48 | Buy |
| 200-day EMA: | 51.43 | Buy |
iShares BB Rated Corporate Bond ETF Earnings Growth & HYBB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.03 per share, and a decrease next year of $3.86 per share.
iShares BB Rated Corporate Bond ETF Technical Analysis
| Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||